Shareholders Equity: The sum of preferred and common equity items.
Clearmind Medicine Inc. (CMND) had Shareholders Equity of $3.11M for the most recently reported fiscal year, ending 2024-10-31.
| Income Statement Financials | |
-- |
|
$-5.25M |
|
-- |
|
-- |
|
$5.74M |
|
$-5.74M |
|
$0.87M |
|
$-4.88M |
|
$-4.81M |
|
$-5.25M |
|
$-5.25M |
|
$-5.25M |
|
$-5.19M |
|
$-5.74M |
|
$-5.73M |
|
0.08M |
|
0.08M |
|
$-67.60 |
|
$-67.60 |
|
| Balance Sheet Financials | |
$7.09M |
|
-- |
|
$0.17M |
|
$7.26M |
|
$4.13M |
|
$0.02M |
|
$0.02M |
|
$4.15M |
|
$3.11M |
|
$3.00M |
|
|
Shareholders Equity |
$3.11M |
0.11M |
|
| Cash Flow Statement Financials | |
$-4.86M |
|
$-0.24M |
|
$6.25M |
|
$5.43M |
|
$6.57M |
|
$1.15M |
|
$0.88M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.72 |
|
-- |
|
-- |
|
0.01 |
|
0.02 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-4.86M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-169.09% |
|
-175.20% |
|
-72.42% |
|
-168.21% |
|
$29.14 |
|
$-62.69 |
|
$-62.69 |
|